On this page
What does a debarment certification address?
The certification addresses the applicant’s past and future use of services of persons debarred under the specified statutory provisions in connection with the application. Abbreviated applications also have a distinct conviction-disclosure task. Build the factual basis for each before authorized review; an empty screening result is not the entire assessment.
Before you begin
The certification in 21 U.S.C. 335a(k) for an application for approval of a drug product. Application-specific conclusions need the responsible regulatory reviewer.
What you will prepare: An evidence-supported certification package for authorized review, with unresolved facts clearly identified.
Separate the legal statement from the supporting work
Section 335a(k) requires an application for approval of a drug product to include a certification addressing the applicant's past and future use of services of persons debarred under the specified statutory provisions in connection with that application. For an abbreviated drug application, the statute separately calls for a list of specified convictions within the previous five years involving the applicant and relevant affiliated persons.
These are related but distinct tasks. Do not treat a debarment-list search as the answer to the separate conviction-disclosure requirement. Have the regulatory or legal owner establish the scope for the actual application and identify the people and records needed to support it.
FDA's October 1998 certification guidance remains labeled draft and not for implementation on its current landing page. It is useful background, but it should not be represented as final guidance or used to invent a universally prescribed filing cadence.
Build a small, traceable evidence file
Recommended working method: name an owner for the factual review and agree how the application team identifies relevant internal and external contributors. Keep the scope, information sources and review date together. Where a team relies on a service provider, identify who can answer questions about the services performed for this application.
Consult the current FDA drug-product-application debarment list and preserve enough information to reproduce any screening decision. A similar name needs identity resolution; it should not automatically be treated as either a match or a cleared result. Escalate uncertainty through the established regulatory/legal process.
List screening is only one input. The signatory needs a factual basis for the actual certification, including the commitment about future services. Ask the responsible owners how future changes will be handled; do not convert an absence of search results into a broader assertion than the evidence supports.
Draft around confirmed facts, not a copied signature block
Use a concise working outline: identify the applicant and application, identify the statutory certification being made, prepare the statement for authorized review, and identify the signing official through the organization's established process. The exact final text and execution should be approved by the responsible owner.
Do not insert a reassuring “none” into a disclosure merely because the author has not received a response. Track missing confirmations as unresolved. For an abbreviated application, assign the additional conviction-list question explicitly; it is easy to overlook when the document title mentions only debarment.
Avoid adding broad warranties about every supplier, every corporate activity or every jurisdiction unless they are deliberately intended and supported. Keep the statement focused on its legal purpose and the application to which it relates. This guide deliberately supplies a preparation outline rather than a ready-to-sign declaration of unknown facts.
Worked review: a name match is not a conclusion
Fictional editorial exercise: a screening result contains the same name as a consultant who contributed to the application. The author cannot establish whether the listed individual and the consultant are the same person.
Record the unresolved match, the source inspected, the identifying information still needed and the owner of the investigation. Do not finalize the certification on an assumption. Equally, do not accuse the consultant of being debarred from a name match alone.
The review is complete only when the relevant identity and applicability questions are resolved through the appropriate process. Keep that determination with the preparation record. The explorer checklist can track completion of this step, but it cannot make the underlying legal determination.
Check the final package and its context
Check that the application identity is consistent with the form and cover letter, the final wording has the intended scope, unresolved questions have been answered, and the signer is authorized under the applicable process. For an abbreviated application, verify that the separately assessed disclosure has a documented disposition.
These reconciliation steps are editorial best practices, not a new statutory form. Record who reviewed the package and when; do not label an automated check as legal approval. Retain the actual evidence and approvals under the organization's record controls.
If the application type or submission stage changes, revisit the conclusion rather than copying an earlier certification unexamined. A source-linked writing guide can help you prepare the document, but it cannot establish the truth of the applicant's statements.
Separate scope, identity resolution and the final statement
Use this working record to make unanswered questions visible before the certificate reaches its signer. It does not prescribe a universal screening process or supply a ready-to-sign declaration.
| Review element | Record | What remains unresolved without it |
|---|---|---|
| Application scope | Applicant, application and relevant services | Which activity the statement actually covers |
| Contributor review | Identified people or entities and information sources | Whether the factual assessment is complete |
| Potential match | Source, identifiers and resolution owner | Whether a similar name identifies the same person |
| Abbreviated-application disclosure | Separate assessment and documented disposition | Whether the conviction-list task was addressed |
| Future-service commitment | Responsible process and owner | How changes affecting the commitment will be handled |
Review exercise: a provider answers “not listed” but the response does not identify whose status was checked or when. Ask for the factual scope and identity resolution supporting that answer. Do not convert a narrow or undated response into a broader certification about unknown services or people.
The final statement should match the actual application identified in Form 356h and the cover letter. Preserve unresolved matters for the accountable reviewer rather than replacing them with reassuring wording.
Source edition: the October 6 review inspected section 306 in the government-hosted GovInfo compilation, whose cover identifies amendments through Public Law 119–75, enacted February 3, 2026. Its August 7 PDF production date is not a later amendment date. The linked official 2024 Code edition remains available for comparison; the House live page returned maintenance. The compilation supports the provisions discussed here but is not the official statutory edition or a claim that every later legal development has been checked for an actual filing.
Your preparation checklist
0/5 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Does a debarment-list search resolve the abbreviated-application conviction disclosure?
No. The certification and the specified conviction disclosure are distinct tasks in subsection (k). Establish the applicable scope and supporting records for each with the responsible reviewer. A search of currently debarred persons does not by itself answer the separate historical conviction question.
Should a matching name be treated as a confirmed debarment finding?
Not from the name alone. Record the potential match and resolve identity and applicability using appropriate evidence and review. Until that is resolved, do not treat the result as either a confirmed accusation or a cleared finding for the proposed certification.
Is FDA’s 1998 debarment-certification guidance final?
The FDA page inspected for this guide still labels the October 1998 document draft and not for implementation. Use it with that status made explicit; the certification obligation is grounded in the statute, not in an assumption that the draft became final.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Statute
FD&C Act section 306: GovInfo statute compilation ↗Retrieved October 6, 2026. Cover and metadata: amended through P.L. 119–75, February 3, 2026; PDF produced August 7, 2026. Section 306(a), (b), (k) and (l)(1), printed pages 34–44, inspected. Government-hosted compilation, not the official statutory edition; production and retrieval dates are not amendment dates.
Statute
21 U.S.C. 335a(k): certification ↗Subsections (k) and (l); last readable consolidated text displayed laws in effect September 12, 2026. October 6 live retry returned maintenance; the dated GovInfo edition and FDA explanation are available below. No new consolidated-law currency claim is made.
Statute
21 U.S.C. 335a: official 2024 edition ↗Official 2024 U.S. Code edition; subsections (k) and (l) inspected October 6, 2026 as a dated primary-source fallback, not a substitute claim of current consolidation.
FDA resource
FDA debarment list: drug product applications ↗Live agency list. Recheck when preparing the actual certification; the guide does not contain a screening result.
Draft guidance
Submitting Debarment Certification Statements ↗October 1998; FDA currently labels this draft, not for implementation. Background only; the obligation is sourced to the statute.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 1.3.3. A heading identifies placement, not mandatory applicability.